Abstract
Purpose: The aim of current study was to develop a dried inactivated polio vaccine (IPV) formulation with minimal loss during the drying process and improved stability when compared with the conventional liquid IPV. Methods: Extensive excipient screening was combined with the use of a Design of Experiment (DoE) approach in order to achieve optimal results with high probability. Results: Although it was shown earlier that the lyophilization of a trivalent IPV while conserving its antigenicity is challenging, we were able to develop a formulation that showed minimal loss of potency during drying and subsequent storage at higher temperatures. Conclusion: This study showed the potential of a highly stable and safe lyophilized polio vaccine, which might be used in developing countries without the need of a cold-chain.
Author supplied keywords
Cite
CITATION STYLE
Kraan, H., Van Herpen, P., Kersten, G., & Amorij, J. P. (2014). Development of thermostable lyophilized inactivated polio vaccine. Pharmaceutical Research, 31(10), 2618–2629. https://doi.org/10.1007/s11095-014-1359-6
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.